In patients with biochemical recurrence after primary radiotherapy for prostate cancer, both the 5-point PRIMARY and E-PSMA Likert scoring systems score demonstrated good performance and substantial interreader agreement between experts for detection of intraprostatic recurrences. Here, FOLH1 is linked to prostate cancer.